Literature DB >> 15358095

Effect of a hyaluronan synthase suppressor, 4-methylumbelliferone, on B16F-10 melanoma cell adhesion and locomotion.

Daisuke Kudo1, Atsushi Kon, Shuichi Yoshihara, Ikuko Kakizaki, Mutsuo Sasaki, Masahiko Endo, Keiichi Takagaki.   

Abstract

Hyaluronan (HA) is a ubiquitous, major component of the extracellular matrix. It is involved in cell adhesion and locomotion, and hence in tumor metastasis. We have previously reported that 4-methylumbelliferone (MU) inhibits HA synthesis and may be a useful tool for examining the functions of HA. We here demonstrate that the formation of cell surface HA by melanoma cells and its release into the culture medium are inhibited by MU. Adhesion and locomotion assays revealed that the adhesion and locomotion of melanoma cells were dose-dependently inhibited by MU. Conversely, treatment with exogenous HA enhanced both adhesion and locomotion. Thus, preventing the formation of cell surface HA reduced both the adhesion and locomotion of melanoma cells, suggesting that MU may act as an inhibitor of tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358095     DOI: 10.1016/j.bbrc.2004.07.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.

Authors:  Vinata B Lokeshwar; Luis E Lopez; Daniel Munoz; Andrew Chi; Samir P Shirodkar; Soum D Lokeshwar; Diogo O Escudero; Neetika Dhir; Norman Altman
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.

Authors:  Aditya G Kohli; Saul Kivimäe; Matthew R Tiffany; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

3.  Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis.

Authors:  Yoshikazu Hirose; Eiko Saijou; Yasuyoshi Sugano; Fumitaka Takeshita; Satoshi Nishimura; Hidenori Nonaka; Yen-Rong Chen; Keisuke Sekine; Taketomo Kido; Takashi Nakamura; Shigeaki Kato; Toru Kanke; Koji Nakamura; Ryozo Nagai; Takahiro Ochiya; Atsushi Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

4.  Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.

Authors:  Naohisa Futamura; Hiroshi Urakawa; Eisuke Arai; Eiji Kozawa; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2013-01-04       Impact factor: 5.150

5.  Synthesis of N-acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis.

Authors:  Gilbert Wasonga; Yota Tatara; Ikuko Kakizaki; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2013-09-02       Impact factor: 1.667

6.  Heparanase modulation by Wingless/INT (Wnt).

Authors:  Carina Mucciolo Melo; Helena Bonciani Nader; Giselle Zenker Justo; Maria Aparecida Silva Pinhal
Journal:  Mol Biol Rep       Date:  2021-04-23       Impact factor: 2.316

7.  Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.

Authors:  E Arai; Y Nishida; J Wasa; H Urakawa; L Zhuo; K Kimata; E Kozawa; N Futamura; N Ishiguro
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

8.  Autocrine Hyaluronan Influences Sprouting and Lumen Formation During HUVEC Tubulogenesis In Vitro.

Authors:  Robert B Vernon; Michel D Gooden; Christina K Chan; Gail Workman; Masanari Obika; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2021-06       Impact factor: 4.137

Review 9.  Targeting hyaluronic acid family for cancer chemoprevention and therapy.

Authors:  Vinata B Lokeshwar; Summan Mirza; Andre Jordan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

10.  Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.

Authors:  Hanna Siiskonen; Mari Poukka; Kristiina Tyynelä-Korhonen; Reijo Sironen; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2013-04-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.